NCT05187351View on ClinicalTrials.gov

Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions

Active, not recruitingOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

November 21, 2021

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Target Vessel Failure in Saphenous Vein GraftsPercutaneous Coronary Intervention
Interventions
PROCEDURE

Percutaneous coronary intervention of the native coronary artery with Synergy

This is a registry study that will enroll patients with a 50-100% de novo SVG lesion and treated with percutaneous coronary intervention of the corresponding native coronary artery using a SYNERGY stent.

Trial Locations (2)

48202

Henry Ford Health System, Detroit

55407

Minneapolis Heart Institute Foundation, Minneapolis

All Listed Sponsors
lead

Minneapolis Heart Institute Foundation

OTHER